Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study
AstraZeneca
David J Jackson; Liam G Heaney; Marc Humbert; Brian D Kent; Anat Shavit; Lina Hiljemark; Lynda Olinger; David Cohen; Andrew Menzies-Gow; Stephanie Korn; SHAMAL Investigators